• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3 炎性小体激活调控动脉粥样硬化中血管平滑肌细胞表型转换。

NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.

机构信息

Division of Cardiology, Foundation for Medical Research, Department of Medicine, Specialized Medicine, Faculty of Medicine, University of Geneva, Av. de la Roseraie 64, 1211 Geneva, Switzerland.

Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 6627, Brazil.

出版信息

Int J Mol Sci. 2021 Dec 29;23(1):340. doi: 10.3390/ijms23010340.

DOI:10.3390/ijms23010340
PMID:35008765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8745068/
Abstract

(1) Background: Monocytes and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome orchestrate lipid-driven amplification of vascular inflammation promoting the disruption of the fibrous cap. The components of the NLRP3 inflammasome are expressed in macrophages and foam cells within human carotid atherosclerotic plaques and VSMCs in hypertension. Whether monocytes and NLRP3 inflammasome activation are direct triggers of VSMC phenotypic switch and plaque disruption need to be investigated. (2) Methods: The direct effect of oxLDL-activated monocytes in VSMCs co-cultured system was demonstrated via flow cytometry, qPCR, ELISA, caspase 1, and pyroptosis assay. Aortic roots of VSMCs lineage tracing mice fed normal or high cholesterol diet and human atherosclerotic plaques were used for immunofluorescence quantification of NLRP3 inflammasome activation/VSMCs phenotypic switch. (3) Results: OxLDL-activated monocytes reduced α-SMA, SM22α, , and upregulation of and macrophage markers MAC2, F4/80 and CD68 expression as well as caspase 1 activation, IL-1β secretion, and pyroptosis in VSMCs. Increased caspase 1 and IL-1β in phenotypically modified VSMCs was detected in the aortic roots of VSMCs lineage tracing mice fed high cholesterol diet and in human atherosclerotic plaques from carotid artery disease patients who experienced a stroke. (4) Conclusions: Taken together, these results provide evidence that monocyte promote VSMC phenotypic switch through VSMC NLRP3 inflammasome activation with a likely detrimental role in atherosclerotic plaque stability in human atherosclerosis.

摘要

(1)背景:单核细胞和核苷酸结合寡聚化结构域样受体蛋白 3(NLRP3)炎性小体协调脂质驱动的血管炎症放大,促进纤维帽破裂。NLRP3 炎性小体的组成部分在人颈动脉粥样硬化斑块中的巨噬细胞和泡沫细胞以及高血压中的血管平滑肌细胞(VSMC)中表达。单核细胞和 NLRP3 炎性小体的激活是否是 VSMC 表型转换和斑块破裂的直接触发因素仍需进一步研究。(2)方法:通过流式细胞术、qPCR、ELISA、caspase 1 和焦亡测定,证明了 oxLDL 激活的单核细胞在共培养系统中的 VSMC 中的直接作用。用正常或高胆固醇饮食喂养的 VSMC 谱系追踪小鼠的主动脉根部和人动脉粥样硬化斑块进行 NLRP3 炎性小体激活/VSMC 表型转换的免疫荧光定量。(3)结果:oxLDL 激活的单核细胞降低了 VSMC 中的α-SMA、SM22α、、并上调了和巨噬细胞标志物 MAC2、F4/80 和 CD68 的表达,以及 caspase 1 的激活、IL-1β 的分泌和焦亡。在喂食高胆固醇饮食的 VSMC 谱系追踪小鼠的主动脉根部和经历中风的颈动脉疾病患者的人动脉粥样硬化斑块中检测到表型修饰的 VSMC 中 caspase 1 和 IL-1β 的增加。(4)结论:综上所述,这些结果提供了证据表明,单核细胞通过 VSMC NLRP3 炎性小体的激活促进 VSMC 表型转换,在人类动脉粥样硬化中可能对动脉粥样硬化斑块稳定性产生不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/b2cca19ed48e/ijms-23-00340-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/3d61c57d9a19/ijms-23-00340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/5e85c3649efb/ijms-23-00340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/55cde8bb6bd5/ijms-23-00340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/ef3e0043d238/ijms-23-00340-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/5d874af10e6f/ijms-23-00340-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/92d49fb4ec26/ijms-23-00340-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/eac7d94e20c3/ijms-23-00340-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/b2cca19ed48e/ijms-23-00340-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/3d61c57d9a19/ijms-23-00340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/5e85c3649efb/ijms-23-00340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/55cde8bb6bd5/ijms-23-00340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/ef3e0043d238/ijms-23-00340-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/5d874af10e6f/ijms-23-00340-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/92d49fb4ec26/ijms-23-00340-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/eac7d94e20c3/ijms-23-00340-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e269/8745068/b2cca19ed48e/ijms-23-00340-g008.jpg

相似文献

1
NLRP3 Inflammasome Activation Controls Vascular Smooth Muscle Cells Phenotypic Switch in Atherosclerosis.NLRP3 炎性小体激活调控动脉粥样硬化中血管平滑肌细胞表型转换。
Int J Mol Sci. 2021 Dec 29;23(1):340. doi: 10.3390/ijms23010340.
2
FNDC5 inhibits foam cell formation and monocyte adhesion in vascular smooth muscle cells via suppressing NFκB-mediated NLRP3 upregulation.FNDC5 通过抑制 NFκB 介导的 NLRP3 上调抑制泡沫细胞形成和血管平滑肌细胞单核细胞黏附。
Vascul Pharmacol. 2019 Oct;121:106579. doi: 10.1016/j.vph.2019.106579. Epub 2019 Jul 15.
3
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.MCC950对NLRP3炎性小体的抑制作用可减少载脂蛋白E缺乏小鼠的动脉粥样硬化病变发展——简要报告
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8.
4
Xanthine Oxidase Induces Foam Cell Formation through LOX-1 and NLRP3 Activation.黄嘌呤氧化酶通过LOX-1和NLRP3激活诱导泡沫细胞形成。
Cardiovasc Drugs Ther. 2017 Feb;31(1):19-27. doi: 10.1007/s10557-016-6706-x.
5
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.胆固醇外排途径抑制炎症小体激活、NETosis 和动脉粥样硬化形成。
Circulation. 2018 Aug 28;138(9):898-912. doi: 10.1161/CIRCULATIONAHA.117.032636.
6
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis.NLRP3炎性小体在颈动脉粥样硬化中的表达
J Stroke Cerebrovasc Dis. 2015 Nov;24(11):2455-66. doi: 10.1016/j.jstrokecerebrovasdis.2015.03.024. Epub 2015 Sep 15.
7
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.虎杖苷通过激活自噬和抑制 NLRP3 炎性体介导的细胞焦亡来防治动脉粥样硬化。
J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2.
8
Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.曲尼司特在调控 NLRP3 泛素化、血管炎症和动脉粥样硬化中的新作用
J Am Heart Assoc. 2020 Jun 16;9(12):e015513. doi: 10.1161/JAHA.119.015513. Epub 2020 Jun 1.
9
RhoGDI3 at the trans-Golgi network participates in NLRP3 inflammasome activation, VSMC phenotypic modulation, and neointima formation.RhoGDI3 在反式高尔基体网络中参与 NLRP3 炎性小体的激活、VSMC 表型调节和新生内膜形成。
Atherosclerosis. 2023 Dec;387:117391. doi: 10.1016/j.atherosclerosis.2023.117391. Epub 2023 Nov 19.
10
MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.微小RNA-155通过ERK1/2途径促进THP-1巨噬细胞中氧化型低密度脂蛋白诱导的NLRP3炎性小体激活,并加重载脂蛋白E基因敲除小鼠的动脉粥样硬化。
Ann Palliat Med. 2019 Nov;8(5):676-689. doi: 10.21037/apm.2019.10.11.

引用本文的文献

1
Resveratrol as a naturally occurring inflammasome modulator: Implications for health and disease.白藜芦醇作为一种天然存在的炎性小体调节剂:对健康与疾病的影响。
Iran J Basic Med Sci. 2025;28(10):1301-1318. doi: 10.22038/ijbms.2025.87366.18879.
2
Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications.心血管疾病中的细胞焦亡:作用、机制及临床意义
Front Cardiovasc Med. 2025 Aug 4;12:1629016. doi: 10.3389/fcvm.2025.1629016. eCollection 2025.
3
Immuno-metabolic diseases and therapeutics: molecular mechanisms via inflammasome signaling.

本文引用的文献

1
An update on the regulatory mechanisms of NLRP3 inflammasome activation.NLRP3 炎性体激活的调控机制研究进展。
Cell Mol Immunol. 2021 May;18(5):1141-1160. doi: 10.1038/s41423-021-00670-3. Epub 2021 Apr 13.
2
Dynamic AFM detection of the oxidation-induced changes in size, stiffness, and stickiness of low-density lipoprotein.动态原子力显微镜检测低密度脂蛋白在氧化诱导下大小、硬度和粘性的变化。
J Nanobiotechnology. 2020 Nov 12;18(1):167. doi: 10.1186/s12951-020-00727-x.
3
Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries.
免疫代谢疾病与治疗:通过炎性小体信号传导的分子机制
Cell Commun Signal. 2025 Aug 19;23(1):373. doi: 10.1186/s12964-025-02368-9.
4
Effects of Mytilus edulis derived plasmalogens against atherosclerosis via lipid metabolism and MAPK signaling pathway.紫贻贝来源的缩醛磷脂通过脂质代谢和MAPK信号通路对动脉粥样硬化的影响。
NPJ Sci Food. 2025 Aug 18;9(1):178. doi: 10.1038/s41538-025-00546-0.
5
Identification and Management Strategies for Intracoronary High Thrombus Burden in Patients With STEMI: A Practical Experience and Literature Review.ST段抬高型心肌梗死患者冠状动脉内高血栓负荷的识别与管理策略:实践经验与文献综述
Rev Cardiovasc Med. 2025 Jul 30;26(7):37466. doi: 10.31083/RCM37466. eCollection 2025 Jul.
6
Vascular Smooth Muscle Cells: A Therapeutic Target in Atherosclerosis.血管平滑肌细胞:动脉粥样硬化的治疗靶点
Rev Cardiovasc Med. 2025 Jun 26;26(6):28240. doi: 10.31083/RCM28240. eCollection 2025 Jun.
7
Hypercholesterolemia, oxidative stress, and low-grade inflammation: a potentially dangerous scenario to blood-brain barrier.高胆固醇血症、氧化应激和低度炎症:对血脑屏障而言的潜在危险情形。
Metab Brain Dis. 2025 May 17;40(5):205. doi: 10.1007/s11011-025-01620-y.
8
PANoptosis: a potential target of atherosclerotic cardiovascular disease.全细胞焦亡:动脉粥样硬化性心血管疾病的一个潜在靶点。
Apoptosis. 2025 Jun;30(5-6):1253-1271. doi: 10.1007/s10495-025-02089-x. Epub 2025 Apr 26.
9
Mitochondrial Dysfunction: A New Hallmark in Hereditable Thoracic Aortic Aneurysm Development.线粒体功能障碍:遗传性胸主动脉瘤发展中的一个新特征。
Cells. 2025 Apr 21;14(8):618. doi: 10.3390/cells14080618.
10
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target.作为治疗靶点的动脉粥样硬化斑块微环境
Curr Atheroscler Rep. 2025 Apr 2;27(1):47. doi: 10.1007/s11883-025-01294-y.
世界卫生组织(WHO)成员国中与心血管疾病相关的死亡风险因素。
Health Soc Care Community. 2022 Jan;30(1):73-80. doi: 10.1111/hsc.13156. Epub 2020 Sep 9.
4
Colchicine in Patients with Chronic Coronary Disease.秋水仙碱治疗慢性冠心病
N Engl J Med. 2020 Nov 5;383(19):1838-1847. doi: 10.1056/NEJMoa2021372. Epub 2020 Aug 31.
5
Stem Cell Pluripotency Genes Klf4 and Oct4 Regulate Complex SMC Phenotypic Changes Critical in Late-Stage Atherosclerotic Lesion Pathogenesis.干细胞多能性基因 Klf4 和 Oct4 调节晚期动脉粥样硬化病变发病机制中关键的复杂 SMC 表型变化。
Circulation. 2020 Nov 24;142(21):2045-2059. doi: 10.1161/CIRCULATIONAHA.120.046672. Epub 2020 Jul 17.
6
The March of Monocytes in Atherosclerosis: One Cell at a Time.单核细胞在动脉粥样硬化中的进展:一次一个细胞
Circ Res. 2020 May 8;126(10):1324-1326. doi: 10.1161/CIRCRESAHA.120.316981. Epub 2020 May 7.
7
Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications.细胞焦亡在心血管疾病中的作用及其治疗意义。
Int J Biol Sci. 2019 May 20;15(7):1345-1357. doi: 10.7150/ijbs.33568. eCollection 2019.
8
Novel Insights Into the NLRP 3 Inflammasome in Atherosclerosis.对动脉粥样硬化中NLRP 3炎性小体的新见解。
J Am Heart Assoc. 2019 Jun 18;8(12):e012219. doi: 10.1161/JAHA.119.012219. Epub 2019 Jun 11.
9
Management of Myocarditis-Related Cardiomyopathy in Adults.成人心肌炎相关性心肌病的管理。
Circ Res. 2019 May 24;124(11):1568-1583. doi: 10.1161/CIRCRESAHA.118.313578.
10
Colchicine: an affordable anti-inflammatory agent for atherosclerosis.秋水仙碱:一种可负担得起的抗动脉粥样硬化炎症药物。
Curr Opin Lipidol. 2018 Dec;29(6):467-473. doi: 10.1097/MOL.0000000000000552.